RIGEL PHARMACEUTICALS INC (RIGL)       1.82  -0.05 (-2.67%)

1.82  -0.05 (-2.67%)

US7665596034 - Common Stock

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.11 -0.14 0.0319.78% Q2 2022 -0.08 -0.13 0.0536.08% Q1 2022 -0.16 -0.14 -0.02-14.26% Q4 2021 -0.13 -0.13 0.000.17% Q3 2021 -0.12 -0.10 -0.02-18.04% Q2 2021 -0.08 -0.12 0.0431.40% Q1 2021 0.22 0.00 0.224,365.55% Q4 2020 -0.11 -0.12 0.015.13%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -0.51 -0.11 -367.04%Q4 2022 -0.14 -0.13 -9.06%FY 2023 -0.26 -0.51 48.58%Q1 2023 -0.03 -0.16 84.06%Q2 2023 -0.09 -0.08 -6.78%Q3 2023 -0.09 -0.11 18.17%Q4 2023 -0.07 -0.14 47.24%FY 2024 -0.15 -0.26 44.02%FY 2025 -0.10 -0.15 31.03%FY 2026 -0.01 -0.10 93.30%FY 2027 0.11 -0.01 1,741.79%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 22.41M 23.062M -652K-2.83% Q2 2022 29.819M 24.128M 5.691M23.59% Q1 2022 16.735M 17.895M -1.16M-6.48% Q4 2021 20.409M 22.337M -1.928M-8.63% Q3 2021 21.543M 24.033M -2.49M-10.36% Q2 2021 26.266M 20.777M 5.489M26.42% Q1 2021 81.02M 31.672M 49.348M155.81% Q4 2020 18.45M 18.463M -13K-0.07%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 93.118M 149.236M -37.60%Q4 2022 22.08M 20.409M 8.19%FY 2023 123.07M 93.118M 32.17%Q1 2023 43.73M 16.735M 161.31%Q2 2023 25.407M 29.819M -14.80%Q3 2023 28.57M 22.41M 27.49%Q4 2023 32.222M 22.08M 45.93%FY 2024 139.23M 123.07M 13.13%FY 2025 175.42M 139.23M 25.99%FY 2026 214.8M 175.42M 22.45%FY 2027 226.91M 214.8M 5.64%